Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Atomoxetine"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringAtomoxetine
brandStringStrattera
structureFile
classesList of String, delimiter: ,[[:Category:NRIs|Selective norepinephrine reuptake inhibitor (NRI)]] [[:Category:ADHD medicines|ADHD medicine]]
mechanismString
usesString'"`UNIQ--vote-00000013-QINU`"'
starting_doseStringChildren ≤70 kg: 0.5 mg/kg/day, titrate to 1.2 mg/kg/day after 3 days. Adults and children >70 kg: 40 mg PO once daily for 3 days, then 80 mg/day, then if needed 100 mg/day after 2-4 weeks
preparationsStringCapsules 10, 18, 25, 40, 60, 80, 100 mg
fda_maxString100 mg/day (adult); 1.4 mg/kg/day or 100 mg total (pediatric, whichever lower)
pill_idText
routesList of String, delimiter: ,Oral
onsetStringADHD effect emerges over 1-2 weeks (slower than psychostimulants); full effect 4-6 weeks
durationString24 hours (once-daily or split BID dosing)
halflifeString~5 hours in extensive CYP2D6 metabolizers; ~21 hours in CYP2D6 poor metabolizers'"`UNIQ--ref-00000014-QINU`"'
bioavailabilityString~63% (oral; extensive first-pass)'"`UNIQ--ref-00000015-QINU`"'
pregnancyStringLimited human data.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. '''Not a controlled substance''', the principal clinical selling point versus psychostimulant ADHD options. Carries the antidepressant-class '''Boxed Warning''' for suicidal ideation in pediatric patients'"`UNIQ--ref-00000016-QINU`"'